Three of the first critical Covid-19 patients treated with the new IgG plasma-derived “passive vaccine” product developed by Israel’s Kamada and Hadassah Medical Center (reported here previously), have made a rapid recovery and have now been discharged from Hadassah hospital.
Covid-19 passive vaccine cures 3 Israelis
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.